Intrapleural treatment in patients with non-small cell lung cancer with malignant pleural effusions in the real world.
Pengfei PanFengjuan WuZhiyun XuXiang JiQian QiXiaomin HuangRuyue ZhaoMingtao LiuPeng JiangYu LiLisheng XuPublished in: Thoracic cancer (2021)
Intrapleural treatment can prolong the survival of NSCLC patients with MPE who do not receive targeted treatment or who only receive chemotherapy. The PE-CEA: B-CEA ratio can be used to predict the efficacy if intrapleural treatment is indicated.
Keyphrases